Darolutamide Plus ADT in Metastatic Hormone-Sensitive Prostate Cancer

(MedPage Today) — New data presented at the American Urological Association (AUA) annual meeting further supported the use of darolutamide (Nubeqa) in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive…